media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Parenteral Drugs (India) Ltd.
( in Crs.)

ParticularsMar 22Mar 21Mar 20Mar 19Mar 18
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]8.5012.1524.0332.00225.92
Other Operating Revenues0.000.027.850.030.31
Total Operating Revenues8.5012.1731.8732.03226.23
      
Other Income0.070.060.251.441.59
Total Revenue8.5712.2332.1333.46227.82
      
EXPENSES     
Cost Of Materials Consumed4.915.935.187.5771.26
Purchase Of Stock-In Trade0.000.350.000.0054.12
Operating And Direct Expenses0.001.6516.3617.9724.96
Changes In Inventories Of FG,WIP And Stock-In Trade0.56-0.621.14-1.1118.60
Employee Benefit Expenses14.7914.5119.2119.9421.93
Finance Costs106.25125.44109.9696.0597.54
Depreciation And Amortisation Expenses40.1517.3317.3569.1224.24
Other Expenses3.262.114.675.3136.52
Total Expenses169.91166.70173.86214.86349.19
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-161.34-154.47-141.74-181.40-121.37
      
Exceptional Items52.210.000.000.000.00
Profit/Loss Before Tax-109.13-154.47-141.74-181.40-121.37
      
Tax Expenses-Continued Operations     
Current Tax-32.760.000.000.000.00
Deferred Tax0.00-32.76-27.66-33.49-9.57
Tax For Earlier Years0.000.000.000.000.02
Total Tax Expenses-32.76-32.76-27.66-33.49-9.56
Profit/Loss After Tax And Before ExtraOrdinary Items-76.36-121.71-114.07-147.91-111.81
      
Profit/Loss From Continuing Operations-76.36-121.71-114.07-147.91-111.81
      
Profit/Loss For The Period-76.36-121.71-114.07-147.91-111.81
Consolidated Profit/Loss After MI And Associates-76.36-121.71-114.07-147.91-111.81
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-25.61-40.82-38.26-49.61-37.50
Diluted EPS (Rs.)-25.61-40.82-38.26-49.61-37.50
ParticularsMar 22
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]8.50
Other Operating Revenues0.00
Total Operating Revenues8.50
Other Income0.07
Total Revenue8.57
EXPENSES 
Cost Of Materials Consumed4.91
Purchase Of Stock-In Trade0.00
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade0.56
Employee Benefit Expenses14.79
Finance Costs106.25
Depreciation And Amortisation Expenses40.15
Other Expenses3.26
Total Expenses169.91
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-161.34
Exceptional Items52.21
Profit/Loss Before Tax-109.13
Tax Expenses-Continued Operations 
Current Tax-32.76
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses-32.76
Profit/Loss After Tax And Before ExtraOrdinary Items-76.36
Profit/Loss From Continuing Operations-76.36
Profit/Loss For The Period-76.36
Consolidated Profit/Loss After MI And Associates-76.36
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-25.61
Diluted EPS (Rs.)-25.61